AR052743A1 - PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS - Google Patents
PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUSInfo
- Publication number
- AR052743A1 AR052743A1 ARP060101408A ARP060101408A AR052743A1 AR 052743 A1 AR052743 A1 AR 052743A1 AR P060101408 A ARP060101408 A AR P060101408A AR P060101408 A ARP060101408 A AR P060101408A AR 052743 A1 AR052743 A1 AR 052743A1
- Authority
- AR
- Argentina
- Prior art keywords
- canarypox virus
- seq
- transfer vector
- plasmidic
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/40—Systems of functionally co-operating vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se provee un virus recombinante a partir del virus canarypox (CNPV), capaz de actuar in vivo como vector de expresion de genes foráneos insertados en regiones genomicas no esenciales para la replicacion viral, con mayor estabilidad genética, donde dichas reguins genomicas corresponden a al menos un gen seleccionado de CNPV018 (SEQ ID No. 1), CNPV048 (SEQ ID No. 2) y CNPV134 (SEQ ID No. 3), del genoma del virus canarypox. Se provee un vector plasmídico de transferencia, suceptible de recombinacion hoologa con un virus canarypox. Además se proveen vacunas y métodos de inmunizacion.A recombinant virus is provided from the canarypox virus (CNPV), capable of acting in vivo as an expression vector of foreign genes inserted in non-essential genomic regions for viral replication, with greater genetic stability, where said genomic reguins correspond to at least a gene selected from CNPV018 (SEQ ID No. 1), CNPV048 (SEQ ID No. 2) and CNPV134 (SEQ ID No. 3), from the canarypox virus genome. A plasmid transfer vector, susceptible to hoologo recombination with a canarypox virus, is provided. In addition, vaccines and immunization methods are provided.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP060101408A AR052743A1 (en) | 2006-04-11 | 2006-04-11 | PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS |
PCT/BR2007/000087 WO2007115385A2 (en) | 2006-04-10 | 2007-04-09 | Transfer plasmidic vector and recombinant canarypox virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP060101408A AR052743A1 (en) | 2006-04-11 | 2006-04-11 | PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS |
Publications (1)
Publication Number | Publication Date |
---|---|
AR052743A1 true AR052743A1 (en) | 2007-03-28 |
Family
ID=37908497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060101408A AR052743A1 (en) | 2006-04-10 | 2006-04-11 | PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR052743A1 (en) |
WO (1) | WO2007115385A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103740758B (en) * | 2013-12-18 | 2015-03-18 | 广东华南联合疫苗开发院有限公司 | Recombinant baculovirus vector, virus like particle, preparation method and use |
CN103710384A (en) * | 2013-12-18 | 2014-04-09 | 广东华南联合疫苗开发院有限公司 | Picornaviridae recombinant vector, virus like particle, and preparation method and use of virus like particle |
CN113388587B (en) * | 2021-07-06 | 2023-09-26 | 天康制药股份有限公司 | Recombinant bovine nodavirus expressing bovine viral diarrhea E2 gene and application thereof |
CN116656730B (en) * | 2023-05-25 | 2024-03-19 | 军事科学院军事医学研究院军事兽医研究所 | Recombinant canary pox virus expressing rabies virus G, M protein and construction method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE71643B1 (en) * | 1990-11-20 | 1997-02-26 | Virogenetics Corp | A recombinant poxviral vaccine for canine distemper |
FR2766091A1 (en) * | 1997-07-18 | 1999-01-22 | Transgene Sa | ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION |
DE10221411B4 (en) * | 2002-05-14 | 2004-07-08 | GSF-Forschungszentrum für Umwelt und Gesundheit GmbH | Recombinant fowlpox virus |
-
2006
- 2006-04-11 AR ARP060101408A patent/AR052743A1/en active IP Right Grant
-
2007
- 2007-04-09 WO PCT/BR2007/000087 patent/WO2007115385A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007115385A2 (en) | 2007-10-18 |
WO2007115385A3 (en) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grimm et al. | Small but increasingly mighty: latest advances in AAV vector research, design, and evolution | |
US20230287401A1 (en) | Rna guided compositions for preventing and treating hepatitis b virus infections | |
Geisler et al. | MicroRNA-regulated viral vectors for gene therapy | |
JP7272952B2 (en) | Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and origin DNA | |
Quabius et al. | Synthetic mRNAs for manipulating cellular phenotypes: an overview | |
ES2610781T3 (en) | Strain independent pathogen amplification and vaccines for these | |
MX2010007336A (en) | Protein expression systems. | |
NZ602504A (en) | Antiviral vaccines with improved cellular immunogenicity | |
WO2010127166A3 (en) | Combination anti-hiv vectors, targeting vectors, and methods of use | |
JP2011004755A5 (en) | ||
JP2010259446A5 (en) | ||
AU2016355468A1 (en) | CMV vectors comprising microRNA recognition elements | |
WO2006069064A3 (en) | Conserved hbv and hcv sequences useful for gene silencing | |
WO2005014806A3 (en) | Conserved hbv and hcv sequences useful for gene silencing | |
ATE494381T1 (en) | IMPROVED EXPRESSION ELEMENTS | |
AR052743A1 (en) | PLASMIDIC TRANSFER VECTOR AND RECOMBINANT CANARYPOX VIRUS | |
RS50977B (en) | Replication-deficient rna viruses as vaccines | |
CN111511914A (en) | Nucleic acid molecules that reduce PAPD5 and PAPD7mRNA for the treatment of hepatitis B infection | |
MX2021004455A (en) | Compositions and methods for delivering transgenes. | |
CN112760320A (en) | Exogenous artificial miRNA for effectively inhibiting porcine epidemic diarrhea virus replication and application thereof | |
CN103627718A (en) | S1 and N double-antigen protein recombinant plasmid capable of expressing IBV (Infectious Bronchitis Virus) and construction method and application thereof | |
Oh et al. | Multi-resistance strategy for viral diseases and in vitro short hairpin RNA verification method in pigs | |
JP5639736B2 (en) | Vector for integration of heterologous genes into the poxvirus genome | |
CN102304580B (en) | Method for screening pig disease resistant breeds, and application thereof | |
JP2009232836A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |